Effect of Insulin on Adiponectin and Adiponectin Receptor-1 Expression in Rats with Streptozotocin-induced Type 2 Diabetes

The present study was designed to investigate the effect of insulin on insulin resistance (IR), plasma adiponectin level and expression of adiponectin receptors 1 (AdipoR1) in obese and streptozotocin-induced type 2 diabetic rats. Male Sprague-Dowley rats were randomized to control group and 3 obese experimental groups. Type 2 diabetic mellitus was induced in the 3rd and 4th experimental groups by given 30 mg/kg of a single dose streptozotocin via intraperitoneal injection (i.p.). Fourth group was treated with i.p. 1 IU insulin/kg/day for 6 days before end of the experiment which lasts for 8 weeks while same amount of normal saline was i.p. given to other group. At the end of the study (8 weeks), plasma levels of adiponectin, triglycerides (TG), cholesterol, fasting blood glucose and insulin were measured. Obesity index (OI) and IR were calculated. AdipoR1 mRNA levels in the soleus muscle tissue were semi-quantitated. Hyperlipidemia, hyperinsulinemia and hyperglycemia were observed in both obese and diabetic rats, which were accompanied by hypoadiponectinemia and down regulation of AdipoR1 expression as compared to the control rats. Adiponectin was negatively correlated with all the biochemical parameters assessed. Insulin treatment significantly improved these metabolic abnormalities and effectively restored adiponectin and AdipoR1 to the control level. In conclusion, adiponectin and its receptor-associated cascade may be aberrantly regulated in both obesity and type 2 diabetes and targeting adiponectin and its receptors may offer a novel therapy against obesity and type 2 diabetes.

[1]  J. De Castro,et al.  Role of insulin receptor substrate-1 serine 307 phosphorylation and adiponectin in adipose tissue insulin resistance in late pregnancy. , 2007, Endocrinology.

[2]  G. Van den Berghe,et al.  Effect of intensive insulin therapy on insulin sensitivity in the critically ill. , 2007, The Journal of clinical endocrinology and metabolism.

[3]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[4]  E. Vartiainen,et al.  Serum cholesterol during 27 years: assessment of systematic error and affecting factors and their role in interpreting population trends. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[5]  C. Mantzoros,et al.  Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. , 2006, The Journal of clinical endocrinology and metabolism.

[6]  M. Beylot,et al.  Expression of the adiponectin receptors AdipoR1 and AdipoR2 in lean rats and in obese Zucker rats. , 2006, Metabolism: clinical and experimental.

[7]  M. Hosseinzadeh‐Attar,et al.  Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet , 2006, Diabetologia.

[8]  A. Seftel Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. , 2005, The Journal of urology.

[9]  E. Mannarino,et al.  The endocrine function of adipose tissue: an update , 2005, Clinical endocrinology.

[10]  T. Kadowaki,et al.  Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.

[11]  E. Rimm,et al.  Association between dietary factors and plasma adiponectin concentrations in men. , 2005, The American journal of clinical nutrition.

[12]  Yan Gao,et al.  Effects of timely insulin treatment on protection of beta cells in a rat model of type 2 diabetes mellitus. , 2004, Chinese medical journal.

[13]  H. Lodish,et al.  A family of Acrp30/adiponectin structural and functional paralogs. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Shankar,et al.  Potentiation of Carbon Tetrachloride Hepatotoxicity and Lethality in Type 2 Diabetic Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.

[15]  A. Greenberg,et al.  Adipocytokines and insulin resistance. , 2004, The Journal of clinical endocrinology and metabolism.

[16]  T. Yanagita,et al.  Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats. , 2003, Biochemical and biophysical research communications.

[17]  Ary L Goldberger,et al.  Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. , 2003, The Journal of clinical endocrinology and metabolism.

[18]  P. Iyengar,et al.  Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. , 2003, Diabetes.

[19]  T. Saruta,et al.  Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. , 2002, Clinical science.

[20]  A. Giacca,et al.  Chronic intraperitoneal insulin delivery, as compared with subcutaneous delivery, improves hepatic glucose metabolism in streptozotocin diabetic rats. , 2000, Metabolism: clinical and experimental.

[21]  C. Deal,et al.  Effects of 14-day infusions of growth hormone and/or insulin-like growth factor I on the obesity of growing Zucker rats. , 1996, Endocrinology.

[22]  Williams Jf Optimization strategies for the polymerase chain reaction. , 1989 .

[23]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[24]  P. Trinder Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor , 1969 .

[25]  M. Lazar The humoral side of insulin resistance , 2006, Nature Medicine.

[26]  R. Henry Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus. , 1996, Annals of internal medicine.

[27]  A. Wahlefeld Triglycerides Determination after Enzymatic Hydrolysis , 1974 .

[28]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .